US FDA adds vision loss warning to weight-loss drugs; Ozempic, Wegovy on the list
New Delhi, Nov 10 (IANS) US health regulators have ordered a new safety warning for widely used weight-loss and diabetes medicines, including Ozempic and Wegovy, after identifying a rare eye condition that can lead to severe and potentially permanent vision loss.